Hypermethylation of RASSF1A in human and rhesus placentas

Area of Science:

• Epigenetics
• Developmental Biology
• Cancer Biology

Background:

• The human placenta shares characteristics with malignant tumors, prompting investigation into shared molecular mechanisms.
• Tumor suppressor gene hypermethylation is a hallmark of many cancers, regulating gene expression epigenetically.

Purpose of the Study:

• To investigate the presence and significance of tumor suppressor gene hypermethylation in the human placenta.
• To explore the epigenetic relationship between the placenta and malignant tumors.

Main Methods:

• Screening of nine tumor suppressor genes for hypermethylation in human placental tissues across all trimesters.
• Utilizing bisulfite sequencing and immunohistochemistry to analyze RASSF1A promoter methylation and gene expression.
• Employing epigenetic drug treatments (5-aza-2'-deoxycytidine and trichostatin A) on choriocarcinoma cell lines.

Main Results:

• Hypermethylation of the Ras association domain family 1 A (RASSF1A) gene was detected in human placentas throughout pregnancy but not in other fetal tissues.
• RASSF1A hypermethylation was also observed in rhesus monkey placentas, but not in mouse placentas, indicating primate-specific epigenetic patterns.
• An inverse correlation between RASSF1A promoter methylation and gene expression was confirmed.
• Epigenetic drug treatments reduced RASSF1A methylation and increased its expression in choriocarcinoma cell lines.

Conclusions:

• The human placenta exhibits epigenetic alterations, specifically RASSF1A gene hypermethylation, mirroring mechanisms found in malignant tumors.
• These findings strengthen the analogy between primate placentas and cancer at the epigenetic level.
• RASSF1A hypermethylation represents a conserved epigenetic phenomenon in primate placentas, potentially linked to its unique biological functions.